Z

Zakarpattia Endoclinic | Gastroenterology Department

Research site

(Unclaimed)

Location

Ivana Chendeya Street 27A, Uzhhorod, Zakarpatska oblast, Ukraine

Site insights

Top conditions

Top treatments

Orforglipron

LY3009104

Baricitinib

LY3502970

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

The purpose of this study is to find out if baricitinib can preserve beta-cell function in participants newly diagnosed with type 1 diabetes. Partici...

Begins enrollment in 1 month

Diabetes Mellitus, Type 1

Drug: Baricitinib

Drug: Placebo

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiova...

Not yet enrolling

Chronic Kidney Disease

Atherosclerosis Cardiovascular Disease

Drug: Orforglipron

Drug: Placebo

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms